Friday, 7 October 2011

Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.

This is not going to please our low fat friends but this is another study casting doubt on the value of low cholesterol.


Conclusion

"Our study provides an updated epidemiological indication of possible errors in the CVD risk algorithms of many clinical guidelines. If our findings are generalizable, clinical and public health recommendations
regarding the 'dangers' of cholesterol should be revised. This is especially true for women, for whom moderately elevated cholesterol (by current standards) may prove to be not only harmless but even
beneficial."

http://www.ncbi.nlm.nih.gov/pubmed/21951982


Graham
at

1 comment:

  1. Anonymous7 October 2011 at 22:05

    I suppose the obsession with lowering cholesterol will carry on unabated, to much money at stake for the big pharma's and the low fat junk food food companies.

    Geordie

    ReplyDelete

The lowcarb team value your comments. Thank you for taking the time to contribute to our blog. Please note! negative comments and insults from anonymous idiots, with nothing to add to the debate will not be authorised. However, we welcome constructive criticism.

The best of health to you and yours.

Eddie